CRS CLINICAL RESEARCH SERVICES


Associated tags: CRS, Bed

Locations: DEUTSCHLAND, KATHERINE, GERMANY

EQS-News: CRS appoints Catherine Canales as new Chief Commercial Officer to fuel strategic development and international growth

Retrieved on: 
Wednesday, April 10, 2024
Research, Culture, Growth, Business, Patient, CRS, Contract research organization, CCO, Marketing, Management

Mannheim, Germany, April 10, 2024 – CRS Clinical Research Services, an expert early-phase Contract Research Organization (CRO), today announced the appointment of Catherine Canales as Chief Commercial Officer (CCO), effective today, completing the new CRS leadership team.

Key Points: 
  • Mannheim, Germany, April 10, 2024 – CRS Clinical Research Services, an expert early-phase Contract Research Organization (CRO), today announced the appointment of Catherine Canales as Chief Commercial Officer (CCO), effective today, completing the new CRS leadership team.
  • Together, they are committed to steering the company's strategic development, growth, and innovation on a global scale.
  • Dr. Elisabeth Lackner, CEO of CRS, commented on the appointment: “It is a great pleasure to welcome Catherine on board the CRS management team.
  • Before that, she served as Director, Business Development at Premier Research, driving business growth and sales by promoting phase I-IV clinical development services.

EQS-News: CRS initiates new chapter by appointing leading industry expert Elisabeth Lackner as Chief Executive Officer

Retrieved on: 
Wednesday, April 10, 2024
University, Growth, Vineta, Patient, Knowledge, Element, CRS, Doctor of Philosophy, Contract research organization, QP, Investment, Qualified person (European Union), CSO, Management

Mannheim, Germany, March 15, 2024 – CRS Clinical Research Services, an expert early-phase Contract Research Organization (CRO), today announced the appointment of Dr. Elisabeth Lackner as Chief Executive Officer (CEO), effective today.

Key Points: 
  • Mannheim, Germany, March 15, 2024 – CRS Clinical Research Services, an expert early-phase Contract Research Organization (CRO), today announced the appointment of Dr. Elisabeth Lackner as Chief Executive Officer (CEO), effective today.
  • Dr. Elisabeth Lackner, CEO of CRS, commented: “I am honoured to join this great management team and to guide the organization into its next chapter of strategic growth and innovation.
  • “Together, we aim to propel CRS to new heights, centred on internationalization, strategic expansion, and a relentless pursuit of excellence."
  • Dr. Lackner is a highly experienced and well-respected global thought leader with over 20 years of experience in the healthcare industry.